Search Results - ariel+isser

1 Results Sort By:
Nanoparticles for Delivery of Immunoregulatory Materials to T Cells
Value Proposition:·        This platform improves current methods for expansion of CD4+ T-cells, which could be used in adoptive transfer therapies.·        Improves modulation, activation, and expansion of T cells over current methods used for CAR T-cell therapyTechnology Description·        Researchers at Johns Hopkins have developed a nanoparticle-based...
Published: 5/10/2024   |   Inventor(s): Jonathan Schneck, Ariel Isser
Keywords(s):  
Category(s): Clinical and Disease Specializations > Immuno-Oncology, Clinical and Disease Specializations > Immunology, Clinical and Disease Specializations > Oncology, Technology Classifications > Engineering Tech, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum